PEG MGF

Overview

PEG MGF (Pegylated Mechano Growth Factor) is a synthetic, stabilized version of MGF, a splice variant of the Insulin-like Growth Factor-1 (IGF-1) gene. The addition of polyethylene glycol (PEG) extends the peptide’s half-life, allowing for longer activity in research models. PEG MGF is studied in laboratory settings for its effects on muscle repair, tissue regeneration, and localized cell growth in preclinical models such as laboratory rodents.

Benefits

Recent preclinical research suggests that PEG MGF may help promote muscle cell repair and regeneration by activating satellite cells and stimulating protein synthesis in damaged muscle tissue. Its pegylated form provides prolonged activity, which allows researchers to study sustained anabolic and recovery effects in test subjects.
Source: Zeng J, et al. PEGylated mechano growth factor E-domain peptide promotes myoblast proliferation and muscle regeneration. Frontiers in Bioengineering and Biotechnology, 2020.

Possible Side Effects

In laboratory research, test subjects administered PEG MGF may show mild side effects such as localized injection site irritation, slight water retention, or temporary muscle tightness depending on dosage, frequency, and study duration. Effects may vary between species and experimental conditions.
Source: Zeng J, et al., Front Bioeng Biotechnol, 2020.

Dosage & Administration

PEG MGF is typically administered via subcutaneous or intramuscular injection under approved laboratory protocols. Typical research dosages range from 200 mcg to 400 mcg per injection, generally administered two to three times per week depending on the study’s duration, test species, and research objectives.
For laboratory research use only. Not for human consumption.

Summary

PEG MGF is a pegylated variant of Mechano Growth Factor developed exclusively for laboratory research investigating muscle repair, tissue regeneration, and satellite cell activation in preclinical models. Research suggests it may support prolonged anabolic effects and muscle recovery with mild side effects such as injection site irritation occasionally noted in test subjects. PEG MGF is administered via subcutaneous or intramuscular injection, with dosage and frequency tailored to each study’s design and species.
Strictly for research purposes only. Not for human use.